A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine
Clinical trial NCT06607380 · COMPLETED
Trial details
- NCT number
- NCT06607380
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-13
- Primary completion
- 2023-04-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.